Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 718
Gene Symbol: C3
C3
0.220 Biomarker disease BEFREE The aim of this study was to investigate the pathogenic role of C3a and C3a receptor (C3aR) in DN. 31798904 2019
Entrez Id: 719
Gene Symbol: C3AR1
C3AR1
0.010 AlteredExpression disease BEFREE The expression of C3aR was examined in the renal specimen of patients with DN. 31798904 2019
Entrez Id: 9844
Gene Symbol: ELMO1
ELMO1
0.400 GeneticVariation disease BEFREE The association of diabetic nephropathy (DN) risk with single nucleotide polymorphisms (SNPs) within Engulfment and Cell Motility 1 (<i>ELMO1</i>) gene and gene-environment synergistic effect have not been extensively examined in, therefore, the purpose of this study is to explore the association between multiple SNPs in <i>ELMO1</i> gene, and the relationship between gene-environment synergy effect and the risk of DN. 31798690 2019
Entrez Id: 64399
Gene Symbol: HHIP
HHIP
0.020 AlteredExpression disease BEFREE We recently reported that hedgehog interacting protein (Hhip), highly expressed in GECs, contributes to DKD development in diabetic mice. 31794697 2020
Entrez Id: 2932
Gene Symbol: GSK3B
GSK3B
0.250 Biomarker disease BEFREE Glycogen synthase kinase 3β hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease. 31791666 2020
Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A
0.300 Biomarker disease BEFREE The present study suggested that interstitial HIF1A may be involved in renal interstitial fibrosis in DN. 31786195 2020
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.600 Biomarker disease BEFREE To investigate the role of microRNA-130b in 1,25(OH)2D3 mediated improvement of renal fibrosis via transforming growth factor-beta 1 in a rat model of diabetic nephropathy (DN). 31781203 2019
Entrez Id: 406920
Gene Symbol: MIR130B
MIR130B
0.040 AlteredExpression disease BEFREE TGF-<i>β</i>1 can decrease the expression of miR-130b in kidney tissues of DN rats. 31781203 2019
Entrez Id: 5806
Gene Symbol: PTX3
PTX3
0.040 Biomarker disease BEFREE PTX3 may be a potential therapeutic target for DKD. 31780874 2019
Entrez Id: 1490
Gene Symbol: CCN2
CCN2
0.300 AlteredExpression disease BEFREE Connective tissue growth factor (CTGF) levels are up-regulated in patients with DN and in renal tubular epithelial cells (RTECs) exposed to high glucose (HG). 31773302 2020
Entrez Id: 4023
Gene Symbol: LPL
LPL
0.030 Biomarker disease BEFREE Altogether, this suggests a potential role for ANGPTL4 in DN perhaps through its role in inhibiting LPL activity and promotes ANGPTL4 as a biochemical marker for the detection of a diabetic kidney disease in patients with T2D. 31772941 2019
Entrez Id: 51129
Gene Symbol: ANGPTL4
ANGPTL4
0.030 Biomarker disease BEFREE Multiple regression analysis showed increased IGFBP1 and TG as predictors of higher ANGPTL4 in people with DN. 31772941 2019
Entrez Id: 3484
Gene Symbol: IGFBP1
IGFBP1
0.010 Biomarker disease BEFREE Multiple regression analysis showed increased IGFBP1 and TG as predictors of higher ANGPTL4 in people with DN. 31772941 2019
Entrez Id: 49
Gene Symbol: ACR
ACR
0.010 Biomarker disease BEFREE The elevation in ANGPTL4 correlated significantly with clinical markers of DN such as ACR, serum creatinine, and eGFR, as well as IGFBP1 and IGFBP4. 31772941 2019
Entrez Id: 3487
Gene Symbol: IGFBP4
IGFBP4
0.010 Biomarker disease BEFREE In this study, our data showed a significant increase in circulating ANGPTL4, IGFBP1, and IGFBP4 in patients with DN. 31772941 2019
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.600 Biomarker disease BEFREE Further exploration indicate that Nrf2 plays pivotal role in AB-38b's attenuation of DN progression through inhibiting NLRP3 inflammasome activation. 31768838 2019
Entrez Id: 114548
Gene Symbol: NLRP3
NLRP3
0.100 Biomarker disease BEFREE Further exploration indicate that Nrf2 plays pivotal role in AB-38b's attenuation of DN progression through inhibiting NLRP3 inflammasome activation. 31768838 2019
Entrez Id: 2551
Gene Symbol: GABPA
GABPA
0.100 Biomarker disease BEFREE Further exploration indicate that Nrf2 plays pivotal role in AB-38b's attenuation of DN progression through inhibiting NLRP3 inflammasome activation. 31768838 2019
Entrez Id: 23771
Gene Symbol: DIANPH
DIANPH
0.100 Biomarker disease BEFREE Therefore, this paper conducted a meta-analysis of the clinical efficacy of acupuncture in the treatment of DN proteinuria, in order to comprehensively analyze the role of acupuncture in the treatment of DN. 31764774 2019
Entrez Id: 2740
Gene Symbol: GLP1R
GLP1R
0.100 Biomarker disease BEFREE This mechanism may explain in part the reno-protective effects of Glp1r agonism in diabetic nephropathy. 31759969 2020
Entrez Id: 9971
Gene Symbol: NR1H4
NR1H4
0.020 Biomarker disease BEFREE Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy. 31759089 2020
Entrez Id: 151306
Gene Symbol: GPBAR1
GPBAR1
0.020 Biomarker disease BEFREE Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy. 31759089 2020
Entrez Id: 836
Gene Symbol: CASP3
CASP3
0.230 AlteredExpression disease BEFREE The oleuropein inhibited cell apoptosis via regulation of MAPK signalling pathways and its downstream targets Bax, caspase-3, and Bcl-2 expression.<b>Conclusion:</b> Oleuropein may server as a favourable additional agent for the treatment of patients with DN. 31755322 2019
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.030 AlteredExpression disease BEFREE The oleuropein inhibited cell apoptosis via regulation of MAPK signalling pathways and its downstream targets Bax, caspase-3, and Bcl-2 expression.<b>Conclusion:</b> Oleuropein may server as a favourable additional agent for the treatment of patients with DN. 31755322 2019
Entrez Id: 19
Gene Symbol: ABCA1
ABCA1
0.060 Biomarker disease BEFREE Furthermore, our group has recently shown that ATP-binding cassette A1 (a protein involved in cholesterol and phospholipid efflux) is significantly reduced in clinical and experimental DKD and that genetic or pharmacological induction of ABCA1 is sufficient to protect from DKD. 31754839 2019